GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (CHIX:PHARMa) » Definitions » Additional Paid-In Capital
中文

Pharming Group (CHIX:PHARMA) Additional Paid-In Capital : €438.7 Mil(As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Pharming Group Additional Paid-In Capital?


Pharming Group's quarterly additional paid-in capital increased from Jun. 2023 (€428.6 Mil) to Sep. 2023 (€446.0 Mil) but then stayed the same from Sep. 2023 (€446.0 Mil) to Dec. 2023 (€438.7 Mil).

Pharming Group's annual additional paid-in capital increased from Dec. 2021 (€402.9 Mil) to Dec. 2022 (€436.4 Mil) and increased from Dec. 2022 (€436.4 Mil) to Dec. 2023 (€438.7 Mil).

Pharming Group Additional Paid-In Capital Historical Data

The historical data trend for Pharming Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Additional Paid-In Capital Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.76 367.54 402.90 436.41 438.72

Pharming Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 436.41 432.65 428.61 446.00 438.72

Pharming Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Pharming Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pharming Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharming Group (CHIX:PHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (CHIX:PHARMa) » Definitions » Additional Paid-In Capital
Comparable Companies
XAMS:BAI XAMS:VVY XAMS:GLPG OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX OCSE:GMAB ALNY BGNE BMRN SZSE:300122 RPRX INCY
Traded in Other Exchanges
PHAR:USA PHGUF:USA PHARM:Netherlands 0QCO:UK PHGN:Germany
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Website
https://www.pharming.com
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (CHIX:PHARMA) Headlines

No Headlines